{"id":"NCT00276484","sponsor":"Organon and Co","briefTitle":"To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)","officialTitle":"A Multicenter, Rand., Double-Blind, Titration Study to Evaluate & Compare the Efficacy & Safety of Ezetimibe Plus Atorvastatin Vs Atorvastatin in Hypercholesterolemic Pts. at High Risk for CHD Not Adequately Controlled on Atorvastatin 40 Mg","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2008-02","completion":"2008-03","firstPosted":"2006-01-13","resultsPosted":"2009-04-13","lastUpdate":"2024-05-14"},"enrollment":579,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"atorvastatin","otherNames":[]},{"type":"DRUG","name":"atorvastatin","otherNames":[]},{"type":"DRUG","name":"ezetimibe","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"To Evaluate and Compare the Efficacy and Safety of Ezetimibe Plus Atorvastatin Versus Atorvastatin in Hypercholesterolemic Patients at High Risk for Coronary Heart Disease Not Adequately Controlled on Atorvastatin 40 mg.","primaryOutcome":{"measure":"Percent Change From Baseline to Week 6 in Low-Density Lipoprotein (LDL)-C","timeFrame":"Baseline and 6 weeks","effectByArm":[{"arm":"Atorvastatin + Ezetemibe","deltaMin":-27.4,"sd":null},{"arm":"Atorvastatin","deltaMin":-11,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19026303","21118495","20151997"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9},"commonTop":["Upper respiratory tract infection","Pain in extremity","Diarrhoea","Myalgia","Headache"]}}